| Retail: $10Approved for 0.5 CE Credit
This article explains the benefit of using FES-PET imaging to predict the clinical benefit of endocrine therapy and its ability to identify tumor heterogeneity. FES-PET’s ability to identify the optimal biopsy site and confirm metastatic diagnosis is also discussed.
The Clinics are scholarly articles licensed from Elsevier to provide additional technical content for ASRT members.
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same biennium.
Free access is included with membership. All titles for which you have not previously earned CE credit appear in your CE library.
Not a member? Call Member Services to join 800-444-2778
